OncoVista Innovative Therapies, Inc. (OTCPK: OVIT)
Health Care · Biotechnology · US
$—
— today · — 1Y
OncoVista Innovative Therapies, Inc. (OTCPK: OVIT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.36K and employs 2 people.
trading between 0.00 and 0.00.
Tweenvest scores OncoVista Innovative Therapies, Inc. across four factors: quality 32/100, value 52/100. Its strongest factor is value.
OVIT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.36K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.15
- Dividend yield
- —
- Beta (5Y)
- -24.16
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.56M
- Employees
- 2
- Next earnings
- —
About OncoVista Innovative Therapies, Inc.
OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The firm produces drug discovery, registration strategies, and emerging technologies. Its products include Cordycepin and L-Nucleoside Conjugate. The company was founded on January 8, 1999 and is headquartered in San Antonio, TX.
- ISIN
- US68232J1051
- Founded
- 2004
- Listed since
- Oct 26, 2007
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Innoveren Scientific Inc.OTCPK: IVRN | $3.20K | $— | — |
| Comera Life Sciences Holdings, Inc.OTCPK: CMRA | $3.07K | $0.00 | — |
| Anthera Pharmaceuticals, Inc.OTCPK: ANTH | $2.62K | $0.00 | — |
| TetraLogic Pharmaceuticals CorporationOTCPK: TLOG | $2.43K | $— | — |
| Lipella Pharmaceuticals Inc.OTCPK: LIPO | $2.31K | $0.00 | -98.47% |
| IMAC Holdings, Inc.OTCPK: BACK | $2.27K | $0.00 | +20.00% |
| Evelo Biosciences, Inc.OTCPK: EVLO | $1.90K | $0.00 | — |
| RegeneRx Biopharmaceuticals, Inc.OTCPK: RGRX | $1.66K | $— | — |
Figures last refreshed Oct 4, 2026.